Net sales

Zimmer Biomet Announces Increased Net Sales in First Quarter 2022 Financial Results

We have not been able to process your request. Please try again later. If you continue to have this problem, please contact [email protected]

Zimmer Biomet Holdings Inc. announced its first quarter 2022 financial results, highlighted by increased net sales and the completion of the ZimVie spin-off, according to a press release.

The company reported net revenue of $1.663 billion in the first quarter, an increase of 3.9% over the prior year period. The company also reported net income of $73 million from continuing operations for the first quarter.

“We are encouraged by the better than expected results seen in the first quarter, driven by the COVID recovery and continued execution by the Zimmer Biomet team. This performance increases our level of confidence for 2022, and we are increasing and tightening our guidance accordingly,” Bryan Hanson, chairman, president and chief executive officer of Zimmer Biomet, said in the release. “Our underlying business remains strong, fueled by innovation in our portfolio and an acceleration of our transformation activities. I continue to be proud of how the Zimmer Biomet team executes our mission so that we can serve healthcare providers and their patients while delivering shareholder value,” added Hanson.